Xeris Pharmaceuticals | Les Charges D'Exploitation



Operating Expenses Changement Date
Adcock Ingram Holdings ZAR 4.23B 196.72M 2024-12
Celltrion KRW 694.31B 569.2B 2025-03
Cspc Pharmaceutical CNY 5.42B 102.74M 2024-09
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Divis Laboratories Ltd 18.06B 1.31B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Kangmei Pharma CNY 1.46B 193.63M 2024-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 311.35M 170.35M 2024-12
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 10.35M 17.73M 2024-06
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Pacira USD 166.93M 4.38M 2025-03
Perrigo USD 1.03B 13.4M 2024-12
Pharma Mar EUR 41.94M 1.53M 2025-03
Qiagen NV USD 377.04M 4.6M 2024-12
Sartorius EUR 745.6M 21.2M 2025-03
Sino Biopharmaceutical CNY 11.66B 5.46B 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Tilray USD 253.17M 16.55M 2024-11
Zz Pientze Pharmaceu 1.96B 275.44K 2025-03



Xeris Pharmaceuticals Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.